News Search Results
Aug 22, 2025, 13:54 ET 6 Panitch Schwarze Lawyers Named Among 2026 'Best Lawyers,' 'Ones to Watch'
fields, and Wieland on the electronics, software, and manufacturing sectors. Ejimonyeugwo focuses on life sciences, pharmaceuticals, software, biotechnology, and engineering, and Lutz assists clients with counseling and opinions relating to life sciences IP. Since it was first published in 1983,
More news about: Panitch Schwarze Belisario & Nadel LLP
Aug 22, 2025, 10:45 ET Ethanol Market Size Will Reach US$162.7 Billion by 2032 as Clean Energy Policies, Biofuel Innovation, and Decarbonization Drive Unprecedented Growth | According to DataM Intelligence
India are leveraging sugarcane, corn, and by-products to expand ethanol production. At the same time, investments in biotechnology and efficient processing techniques are enhancing yields and improving sustainability. Advanced production methods, including cellulosic
More news about: DataM Intelligence 4 Market Research LLP
Aug 22, 2025, 10:01 ET Epigenetics Market is expected to generate a revenue of USD 3.70 Billion by 2031, Globally, at 13.94% CAGR: Verified Market Research®
data.Applications in oncology, neurology, and cardiovascular diseases are fueling demand for advanced epigenetic platforms.Pharmaceutical and biotechnology firms are channeling heavy investments into epigenetic research to enhance personalized therapies.Growing awareness among clinicians and
More news about: Verified Market Research
Aug 22, 2025, 10:01 ET Walking Aids Market to Register 7.2% CAGR to Reach US$29.31 Billion by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Aug 22, 2025, 09:00 ET Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 22, 2025, 08:00 ET WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES
future growth, ensuring both healthy development and steady progress. We intend to bolster our standing as a GMP manufacturer that sets the bar in biotechnology production." About IQI Media: Headquartered in Los Angeles, California, IQI Media Inc. is
More news about: Winvest Group Ltd
Aug 21, 2025, 13:43 ET Rubin and Rudman Adds Dawn Stolfi Stalenhoef as a Partner in Environmental, Land Use & Zoning Practice Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Aug 21, 2025, 13:30 ET Paragon Therapeutics Expands Executive Team to Advance Strategic Objectives
WALTHAM, Mass., Aug. 21, 2025 /PRNewswire/ -- Paragon Therapeutics, a biotechnology company that applies cutting-edge science and technology to design the next generation of best-in-class complex biologics for major medical needs,
More news about: Paragon Therapeutics
Aug 21, 2025, 12:45 ET Harnessing the Power of Laboratory Data to Optimize Trial Design, Site Identification and Patient Recruitment, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 12:44 ET STAT Announces 2025 Rankings of Biotech's Top Venture Capital Firms
groundbreaking health care innovations. These firms have been instrumental in funding startups and companies that are at the forefront of medical research, biotechnology, and digital health. The report comes as the biotech industry faces a series of existential questions and the National Institutes of Health
More news about: STAT
Aug 21, 2025, 12:30 ET Biomedical Polyurethane Technologies for Medical Device Innovation, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 12:28 ET Rubin and Rudman Announces 30 Lawyers Selected for 2026 Best Lawyers in America
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Aug 21, 2025, 10:30 ET Disposable Surgical Gloves Market is Growing at 10.1% CAGR to Reach US$5.18 billion by 2031; Due to Rising Number of Surgical Procedures | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 21, 2025, 10:01 ET Tangential Flow Filtration Market worth $3.20 billion by 2030 with 11.4% CAGR | MarketsandMarkets™
end users, the tangential flow filtration market is segmented into pharmaceutical & biotechnology companies, CMOs & CROs, and academic & research institutes. The pharmaceutical & biotechnology companies' segment is estimated to register the highest growth rate during the forecast period,
More news about: MarketsandMarkets
Aug 21, 2025, 10:01 ET Cystoscopy and Ureteroscopy Market is Growing at 6.9% CAGR to Reach US$729.30 million by 2031; Due to Increasing Prevalence of Urological Diseases | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 21, 2025, 08:30 ET AI in Molecular Biology: Revolutionizing the Future of Biotech, Upcoming Webinar Hosted by Xtalks
The featured speaker will discuss how streamlined workflows with AI-driven platforms reduce development time and simplify research processes in biotechnology and life sciences. Attendees will learn how accelerated innovation facilitates breakthroughs in synthetic biology, drug discovery, gene therapy
More news about: Xtalks
Aug 21, 2025, 08:30 ET Multidomain Biologics: Bioanalytical Strategies and Insights, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 21, 2025, 08:30 ET Dan Kagan, Scientist.com President and COO, Named Among Top 25 BioTech and Life Sciences Executives of 2025 by The Healthcare Technology Report
and operational leadership, contributions to therapeutic innovation and platform development, and their ability to advance the broader field of biotechnology and life sciences. Scientist.com congratulates Dan Kagan and the other outstanding recipients for their exceptional
More news about: Scientist.com
Aug 21, 2025, 08:30 ET ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment
investment manager based in Austin, Texas, focused on public and private equity investments in the life sciences and biotechnology sectors. The firm was founded in October 2018 by Dr. Daniel Schneeberger, who brings
More news about: ADAR1 Capital Management, LLC
Aug 21, 2025, 08:00 ET Andelyn Biosciences and Amplo Biotechnology Partner to Manufacture Novel Gene Therapies for Diseases Affecting the Neuromuscular Junction
advantages clients in bringing their critical therapies to market. For more information, visit andelynbio.com. About Amplo Biotechnology, Inc. Amplo Biotechnology is a late-stage preclinical company developing regenerative AAV gene therapies with an initial focus on restoring NMJ function
More news about: Andelyn Biosciences
Aug 21, 2025, 08:00 ET STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF ELAMIPRETIDE NDA RESUBMISSION
Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced
More news about: Stealth BioTherapeutics Inc.
Aug 21, 2025, 08:00 ET Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
Aug. 21, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Aug 21, 2025, 07:23 ET Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer
clinical report prepared for regulatory purposes. About Hamlet BioPharma Hamlet BioPharma is an innovative biotechnology company that develops scientific discoveries into drugs for the treatment of cancer and infections. The goal is to address unmet medical needs in
More news about: Hamlet BioPharma AB (publ)
Aug 21, 2025, 06:02 ET Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results
Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health across diseases with high unmet medical need, today provided a corporate update and reported
More news about: Brii Biosciences Limited